MarketInOut Stock Screener Log In | Sign Up

Venus Remedies Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:52
Venus Remedies Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization18,966 mln
Float6.87 mln

EPS

86.91
Exceptional

P / E

15.91
Moderately valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.82
Likely reliable

Relative Strength

8 / 100
Severely lagging

Debt / Equity

0.02
Debt-free

Business Description

Founded in 1989 and based in Panchkula, India, Venus Remedies Limited is a pharmaceutical company that operates both locally and across global markets. The company develops and sells a wide range of medical treatments, covering areas such as infections, cancer, heart health, pain relief, and immunity, among others. A key focus of its research efforts is tackling the growing challenge of antibiotic resistance.

Key Fundamentals

EPS86.91
P/E15.91
ROE19.16
RPS607
ROIC20.36
ROA14.91
Interest Cover4,661
EBITDA, mln1,779
EV / EBITDA12.34
EV / EBIT14.48
Revenue, mln8,113
EV / Revenue2.71

Quote Details

Last 1,382.60
Change -82.4 (-5.62%)
Open 1,528.00
Volume 22,781
Turnover 31,497,010
Average Volume 5,031.1

Financial Ratios

Pre-Tax Profit Margin19
Current Ratio2.44
Price / Book3.62
Price / Tangible Book4.21
Price / Cash Flow23.45
Price / Free Cash Flow20.08
Debt / Equity0.02
Price / Sales2.96
PEG Ratio2.32

Financial Strength

Altman Z-Score9.61
Piotroski F-Score 6 / 9
Beneish M-Score-2.82
Price to Intrinsic Value1.62
Price to Lynch Fair Value1.73
Price to Graham Number2.09
Shiller PE Ratio46.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -14.07% 5 / 100   
1 Month -14.67% 20 / 100   
2 Months -19.94% 20 / 100   
6 Months 46.67% 92 / 100   
1 Year 203% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog